Tradename: CYFENDUS

Proper Name: Anthrax Vaccine Adsorbed, Adjuvanted 

Indication: Indicated for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs.                               

Approval Date: 07/20/2023

Manufacturer: Emergent Product Development Gaithersburg Inc.


Leave a Reply

Your email address will not be published. Required fields are marked *